Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: A multicenter experience

Journal of Clinical Oncology

Volumn 25, Issue 29, 2007, Pages 4581-4586

  Salama, Joseph K ^a   Mell, Loren K ^a   Schomas, David A ^a   Miller, Robert C ^a   Devisetty, Kiran ^a   Jani, Ashesh B ^a   Mundt, Arno J ^a   Roeske, John C ^a   Liauw, Stanley L ^a   Chmura, Steven J ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN;

ADULT; AGED; ANEMIA; ANUS CARCINOMA; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESQUAMATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INGUINAL LYMPH NODE; INTENSITY MODULATED RADIATION THERAPY; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NEUTROPENIA; OVERALL SURVIVAL; PELVIS; PRIORITY JOURNAL; RADIATION DOSE; SCORING SYSTEM; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; TERTIARY HEALTH CARE; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT PLANNING; UNIVERSITY HOSPITAL; UROGENITAL TRACT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 35648948442     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.12.0170     Document Type: Article

References (25)

1. American Cancer Society: Cancer Facts & Figures 2003. http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf
2. Boman BM, Moertel CG, O'Connell MJ, et al: Carcinoma of the anal canal: A clinical and pathologic study of 188 cases. Cancer 54:114-125, 1984
3. Frost DB, Richards PC, Montague ED, et al: Epidermoid cancer of the anorectum. Cancer 53:1285-1293, 1984
4. Greenall MJ, Quan SH, Urmacher C, et al: Treatment of epidermoid carcinoma of the anal canal. Surg Gynecol Obstet 161:509-517, 1985
5. Papillon J, Montbarbon JF: Epidermoid carcinoma of the anal canal: A series of 276 cases. Dis Colon Rectum 30:324-333, 1987
6. Salmon RJ, Fenton J, Asselain B, et al: Treatment of epidermoid anal canal cancer. Am J Surg 147:43-48, 1984
7. Nigro ND, Vaitkevicius VK, Considine B Jr: Combined therapy for cancer of the anal canal: A preliminary report. Dis Colon Rectum 17:354-356, 1974
8. Nigro ND, Seydel HG, Considine B, et al: Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal. Cancer 51:1826-1829, 1983
9. Allal A, Kurtz JM, Pipard G, et al: Chemoradiotherapy versus radiotherapy alone for anal cancer: A retrospective comparison. Int J Radiat Oncol Biol Phys 27:59-66, 1993
10. Cummings BJ, Keane TJ, O'Sullivan B, et al: Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 21:1115-1125, 1991
11. UKCCCR Anal Cancer Trial Working Party, UK Co-ordinating Committee on Cancer Research: Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 348:1049-1054, 1996
12. Bartelink H, Roelofsen F, Eschwege F, et al: Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15:2040-2049, 1997
13. Flam M, John M, Pajak TF, et al: Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study. J Clin Oncol 14:2527-2539, 1996
14. Gunderson LL, Winter K, Ajani J, et al: In Intergroup RTOG 98-11 phase III comparison of chemoradiation with 5-FU and mitomycin vs 5-FU and cisplatin for anal canal carcinoma: Impact on disease free survival, overall, and colostomy free survival. Presented at Annual Meeting of the American Society of Therapeutic Radiology and Oncology, 2006, Philadelphia, PA
15. Teh BS, Woo SY, Butler EB: Intensity modulated radiation therapy (IMRT): A new promising technology in radiation oncology. Oncologist 4:433-442, 1999
16. Mell LK, Roeske JC, Mundt AJ: A survey of intensity-modulated radiation therapy use in the United States. Cancer 98:204-211, 2003
17. Eisbruch A, Ship JA, Dawson LA, et al: Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg 27:832-837, 2003
18. Zelefsky MJ, Fuks Z, Leibel SA: Intensity-modulated radiation therapy for prostate cancer. Semin Radiat Oncol 12:229-237, 2002
19. Salama JK, Roeske JC, Mehta N, et al: Intensity-modulated radiation therapy in gynecologic malignancies. Curr Treat Options Oncol 5:97-108, 2004
20. John M, Pajak T, Flam M, et al: Dose escalation in chemoradiation for anal cancer: Preliminary results of RTOG 92-08. Cancer J Sci Am 2:205-211, 1996
21. Milano MT, Jani AB, Farrey KJ, et al: Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: Toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 63:354-361, 2005
22. Brixey CJ, Roeske JC, Lujan AE, et al: Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 54:1388-1396, 2002
23. Mell LK, Kochanski JD, Roeske JC, et al: Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys 66:1356-1365, 2006
24. Mell LK, Salama JK, Roeske JC, et al: Dosimetric predictors of acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity modulated radiation therapy (IMRT). Int J Radiat Oncol Biol Phys 66:S277-S278, 2006
25. Mell LK, Aydogan B, Salama JK, et al: Bone marrow-sparing intensity-modulated radiation therapy versus conventional techniques for pelvic inguinal irradiation in anal cancer. Presented at Annual Meeting of the American Radium Society, November 5-9, 2006, Amsterdam, the Netherlands